A cost-utility analysis of interferon beta for multiple sclerosis.
暂无分享，去创建一个
A. Jacoby | D. Parkin | S. Thomas | D Bates | S Thomas | D Parkin | P McNamee | A Jacoby | P Miller | P. Miller | D. Bates | P McNamee
[1] Paul Kind,et al. A social tariff for EuroQol: results from a UK general population survey , 1995 .
[2] M. Kremenchutzky. [The natural history of multiple sclerosis]. , 2000, Revista de neurologia.